HK1062170A1 - Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds - Google Patents
Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compoundsInfo
- Publication number
- HK1062170A1 HK1062170A1 HK04105132A HK04105132A HK1062170A1 HK 1062170 A1 HK1062170 A1 HK 1062170A1 HK 04105132 A HK04105132 A HK 04105132A HK 04105132 A HK04105132 A HK 04105132A HK 1062170 A1 HK1062170 A1 HK 1062170A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- denes
- aryl
- substituted
- preparation
- fused azapolycyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28513101P | 2001-04-20 | 2001-04-20 | |
PCT/IB2002/000660 WO2002085843A2 (en) | 2001-04-20 | 2002-03-04 | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1062170A1 true HK1062170A1 (en) | 2004-10-21 |
Family
ID=23092860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04105132A HK1062170A1 (en) | 2001-04-20 | 2004-07-14 | Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds |
Country Status (25)
Country | Link |
---|---|
US (2) | US7091372B2 (cs) |
EP (1) | EP1383733B1 (cs) |
JP (1) | JP2004527545A (cs) |
KR (1) | KR100551183B1 (cs) |
CN (1) | CN1321107C (cs) |
AR (2) | AR035957A1 (cs) |
AT (1) | ATE388135T1 (cs) |
AU (1) | AU2002234836B2 (cs) |
BR (1) | BR0208992A (cs) |
CA (1) | CA2443946A1 (cs) |
CZ (1) | CZ20032814A3 (cs) |
DE (1) | DE60225433T2 (cs) |
DK (1) | DK1383733T3 (cs) |
ES (1) | ES2300430T3 (cs) |
HK (1) | HK1062170A1 (cs) |
HU (1) | HUP0303811A3 (cs) |
IL (1) | IL157881A0 (cs) |
MX (1) | MXPA03009527A (cs) |
PL (1) | PL366657A1 (cs) |
PT (1) | PT1383733E (cs) |
RU (1) | RU2282619C9 (cs) |
TW (1) | TWI244472B (cs) |
WO (1) | WO2002085843A2 (cs) |
YU (1) | YU78303A (cs) |
ZA (1) | ZA200307205B (cs) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE447772T1 (de) * | 2001-11-16 | 2009-11-15 | Cdt Oxford Ltd | Leuchtdiode und verwendete verbindungen |
RU2284319C2 (ru) * | 2002-11-25 | 2006-09-27 | Пфайзер Продактс Инк. | Усовершенствованный способ получения 1,3-замещенных инденов |
US20070066827A1 (en) * | 2003-01-15 | 2007-03-22 | Pfizer Inc. | Process for the preparation of aryl fused polycyclic lactams |
DE602004015986D1 (de) * | 2003-06-04 | 2008-10-02 | Pfizer Prod Inc | Herstellung von substituierten chinoxalinen aus den dianilinen mit 2,3-dihydroxy-1,4-dioxan |
WO2005007630A2 (en) * | 2003-07-21 | 2005-01-27 | Pfizer Products Inc. | Aryl fused azapolycyclic compounds |
CN101309903B (zh) * | 2005-11-16 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 制备thoc的新方法 |
DE102006024903A1 (de) * | 2006-05-24 | 2007-11-29 | Basf Ag | Verfahren zur Vermeidung von Fumarsäureablagerungen bei der Herstellung von Maleinsäureanhydrid |
CN103463086B (zh) | 2007-05-16 | 2015-10-21 | 塔科达有限责任公司 | 作为pde4抑制剂的吡唑啉酮衍生物 |
EP2019107A1 (en) | 2007-07-26 | 2009-01-28 | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik | Use of phosphonium salts in coupling reactions and process for their manufacture |
WO2009065872A2 (en) * | 2007-11-20 | 2009-05-28 | Medichem, S.A. | Improved processes for the synthesis of varenicline l-tartrate |
EP2260037A2 (en) * | 2008-02-15 | 2010-12-15 | Medichem, S.A. | A polymorphic form of a pyrazino [2,3-h] [3] benzazepine derivative |
WO2009143347A2 (en) * | 2008-05-22 | 2009-11-26 | Teva Pharmaceutical Industries Ltd. | Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
US20090318695A1 (en) * | 2008-06-19 | 2009-12-24 | Vinod Kumar Kansal | Processes for the preparation of varenicline and intermediates thereof |
US20100010221A1 (en) * | 2008-07-10 | 2010-01-14 | Revital Lifshitz-Liron | Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
EP2438054A1 (en) | 2009-06-22 | 2012-04-11 | Teva Pharmaceutical Industries Ltd. | Solid states forms of varenicline salts and processes for preparation thereof |
US20120004239A1 (en) | 2010-06-11 | 2012-01-05 | Medichem, S.A. | Process for Preparing Quinoxaline Derivatives |
KR101603427B1 (ko) * | 2014-08-14 | 2016-03-15 | 영남대학교 산학협력단 | 케스케이드 반응을 통한 인덴 유도체의 효율적 합성방법 |
CN104478803A (zh) * | 2014-12-19 | 2015-04-01 | 连云港恒运医药科技有限公司 | 伐尼克兰中间体及其硝基还原杂质的制备方法 |
EP3334703A4 (en) * | 2015-08-14 | 2019-07-03 | Boulos & Cooper Pharmaceuticals PTY Ltd | SYNTHESIS OF ARYLIC COMPOUNDS |
AU2017293925B2 (en) | 2016-07-07 | 2022-02-03 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
SG11202004246YA (en) * | 2017-11-10 | 2020-06-29 | Hughes Howard Med Inst | Modified ligand-gated ion channels and methods of use |
CN111995519B (zh) * | 2020-09-26 | 2022-08-26 | 安徽金禾实业股份有限公司 | 一种3-甲氧基丙烯酸甲酯的制备方法 |
CN115322105A (zh) * | 2021-05-11 | 2022-11-11 | 江苏润安制药有限公司 | 一种合成艾拉莫德关键中间体的方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5479598A (en) * | 1992-10-23 | 1995-12-26 | International Business Machines Corporation | Compact graphical parallel program user output interface controlled directly by the parallel computer program |
EP0636985B1 (en) * | 1993-07-27 | 1998-04-08 | International Business Machines Corporation | Process monitoring in a multiprocessing server |
US6289368B1 (en) * | 1995-12-27 | 2001-09-11 | First Data Corporation | Method and apparatus for indicating the status of one or more computer processes |
US5928323A (en) * | 1996-05-30 | 1999-07-27 | Sun Microsystems, Inc. | Apparatus and method for dynamically generating information with server-side software objects |
FR2751448B1 (fr) * | 1996-07-17 | 1999-01-15 | Bull Sa | Procede de surveillance en temps reel d'un systeme informatique pour son administration et l'aide a sa maintenance en phase d'exploitation |
US6112194A (en) * | 1997-07-21 | 2000-08-29 | International Business Machines Corporation | Method, apparatus and computer program product for data mining having user feedback mechanism for monitoring performance of mining tasks |
US6119165A (en) * | 1997-11-17 | 2000-09-12 | Trend Micro, Inc. | Controlled distribution of application programs in a computer network |
US6100887A (en) * | 1997-12-05 | 2000-08-08 | At&T Corporation | Reusable reversible progress indicator software component for a graphical user interface |
US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
PT1044189E (pt) * | 1997-12-31 | 2008-04-22 | Pfizer Prod Inc | Compostos azapolicíclicos condensados com arilo |
US6151357A (en) * | 1998-01-16 | 2000-11-21 | Aspect Communications Corporation | Method and apparatus for displaying a visual indication of a transmission status |
US6108003A (en) * | 1998-03-18 | 2000-08-22 | International Business Machines Corporation | Maintaining visibility and status indication of docked applications and application bars |
ATE258921T1 (de) * | 1998-04-29 | 2004-02-15 | Pfizer Prod Inc | Aryl-annellierte azapolycyclische verbindungen |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
AU5667100A (en) * | 1999-07-02 | 2001-01-22 | Prescient Neuropharma Inc. | Novel aminoindanes |
IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
US20010036949A1 (en) * | 2000-05-09 | 2001-11-01 | Coe Jotham Wadsworth | Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal |
US20020010192A1 (en) * | 2000-06-02 | 2002-01-24 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
-
2002
- 2002-03-04 CZ CZ20032814A patent/CZ20032814A3/cs unknown
- 2002-03-04 ES ES02701498T patent/ES2300430T3/es not_active Expired - Lifetime
- 2002-03-04 KR KR1020037013659A patent/KR100551183B1/ko not_active IP Right Cessation
- 2002-03-04 CA CA002443946A patent/CA2443946A1/en not_active Abandoned
- 2002-03-04 BR BR0208992-0A patent/BR0208992A/pt not_active IP Right Cessation
- 2002-03-04 PT PT02701498T patent/PT1383733E/pt unknown
- 2002-03-04 DE DE60225433T patent/DE60225433T2/de not_active Expired - Fee Related
- 2002-03-04 AU AU2002234836A patent/AU2002234836B2/en not_active Ceased
- 2002-03-04 RU RU2003130751/04A patent/RU2282619C9/ru not_active IP Right Cessation
- 2002-03-04 HU HU0303811A patent/HUP0303811A3/hu unknown
- 2002-03-04 CN CNB028085124A patent/CN1321107C/zh not_active Expired - Fee Related
- 2002-03-04 IL IL15788102A patent/IL157881A0/xx unknown
- 2002-03-04 MX MXPA03009527A patent/MXPA03009527A/es active IP Right Grant
- 2002-03-04 JP JP2002583371A patent/JP2004527545A/ja active Pending
- 2002-03-04 YU YU78303A patent/YU78303A/sh unknown
- 2002-03-04 WO PCT/IB2002/000660 patent/WO2002085843A2/en active IP Right Grant
- 2002-03-04 EP EP02701498A patent/EP1383733B1/en not_active Expired - Lifetime
- 2002-03-04 PL PL02366657A patent/PL366657A1/xx not_active Application Discontinuation
- 2002-03-04 DK DK02701498T patent/DK1383733T3/da active
- 2002-03-04 AT AT02701498T patent/ATE388135T1/de not_active IP Right Cessation
- 2002-04-15 TW TW091107632A patent/TWI244472B/zh not_active IP Right Cessation
- 2002-04-17 US US10/124,135 patent/US7091372B2/en not_active Expired - Fee Related
- 2002-04-18 AR ARP020101424A patent/AR035957A1/es active IP Right Grant
-
2003
- 2003-09-15 ZA ZA200307205A patent/ZA200307205B/en unknown
-
2004
- 2004-03-17 AR ARP040100885A patent/AR043636A2/es active IP Right Grant
- 2004-07-14 HK HK04105132A patent/HK1062170A1/xx not_active IP Right Cessation
-
2005
- 2005-11-23 US US11/286,055 patent/US7186870B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1062170A1 (en) | Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds | |
HUP9900163A3 (en) | Process for the preparation of sterol-and stanol-esters, and use thereof | |
HK1098737A1 (en) | Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane | |
AU2003233010A8 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
AP2000002010A0 (en) | Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof | |
PL371122A1 (en) | Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols | |
IL145520A0 (en) | Flame-retarding composition and process for the preparation thereof | |
GB0126643D0 (en) | Composition and process | |
IL139023A0 (en) | Process for the preparation of 2,3,5-trimethyl-p- benzoquinone | |
GB0020717D0 (en) | Novel compounds and process | |
HUP0401577A3 (en) | Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses | |
HUP0402544A3 (en) | Composition for electrolytic solution and process for producing the same | |
GB9917593D0 (en) | Compound, composition, process and use | |
GB0014580D0 (en) | Appatarus and process | |
PL345068A1 (en) | Novel compounds derived from α-d-xylose, preparation method and therapeutic use | |
EP1396534A4 (en) | PERFUME COMPOSITION AND PROCESS FOR PRODUCING THE SAME | |
EP1295864A4 (en) | PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES | |
IL137364A (en) | Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol | |
SG95675A1 (en) | Process for the preparation of 2,6-xylenol | |
HK1041606B (zh) | N,n'-羰基雙內酰胺的製備方法 | |
HUP0100584A3 (en) | Triazepinones, process for their preparation and their therapeutic application | |
GB0126647D0 (en) | Composition and process | |
GB0126644D0 (en) | Composition and process | |
GB0126646D0 (en) | Composition and process | |
AU2002315953A1 (en) | Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110304 |